Literature DB >> 9051691

Clinicopathologic study of nasal T/NK-cell lymphoma among the Japanese.

S Nakamura1, E Katoh, T Koshikawa, Y Yatabe, T Nagasaka, H Ishida, Y Tokoro, K Koike, Y Kagami, M Ogura, M Kojima, Y Nara, Y Mizoguchi, K Hara, S Kurita, M Seto, T Suchi.   

Abstract

A high prevalence of nasal lymphoma expressing a T- or natural killer (NK)-cell phenotype (NTCL) with frequent association of Epstein-Barr virus (EBV) has been indicated in Asians. To characterize NTCL among the Japanese, the clinicopathologic features of 32 cases were evaluated and the cases were also analyzed for EBV-RNA using an ISH method. Morphologically, 31 cases were identified by atypical pleomorphic lymphoid infiltrates with polymorphous, angicentric, and necrotic features. Their lymphoma cells ranged in size from small to large and were mixed in varying proportion from case to case. The other one case showed a monomorphic 'blastic' appearance. EBV-encoded small RNA (EBER) was detected in the neoplastic cells of 27 of the 32 cases examined. In the five EBV-negative cases, one was the 'blastic' type. Clonal T-cell receptor gene rearrangement was detected in none of seven cases examined. The patients had a median follow-up of 9 months (range, 1 month to 14 years and 11 months). The Kaplan-Meier estimate of overall survival was 49% at 5 years, correlating with clinical stage. These data support the concept that most cases of NTCL are identified as tumors with T/NK-cell characteristics and EBV association, distinctly different from other peripheral T-cell lymphomas. Furthermore, the one case of an EBV-negative 'blastic' variant appears not to fit well into the pleomorphic category but more closely resembles the pathologic features of extranasal angiocentric lymphoma with lymphoblastoid appearance. This study also showed no clear difference in clinical aspects other than the original site or in prognosis, between NTCL and extranasal angiocentric lymphomas despite the higher incidence of EBV association and the tendency for that peculiar anatomical site to be restricted to the former group.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9051691     DOI: 10.1111/j.1440-1827.1997.tb04433.x

Source DB:  PubMed          Journal:  Pathol Int        ISSN: 1320-5463            Impact factor:   2.534


  12 in total

1.  L-asparaginase-based regimen as a first-line treatment for newly diagnosed nasal type extranodal natural killer cell/T-cell lymphoma.

Authors:  Shanshan Bu; Fangfang Yuan; Xudong Wei; Qingsong Yin; Yufu Li; Ruihua Mi; Haiping Yang; Hongyi Li; Shoubei Ge; Yanyan Liu; Yongping Song
Journal:  Exp Ther Med       Date:  2016-04-11       Impact factor: 2.447

2.  Pregnancy-associated cytotoxic lymphoma: a report of 4 cases.

Authors:  M Kato; K Ichimura; Y Hayami; S Iida; A Wakita; R Ueda; S Nakamura
Journal:  Int J Hematol       Date:  2001-08       Impact factor: 2.490

3.  p53 Mutations in nasal natural killer/T-cell lymphoma from Mexico: association with large cell morphology and advanced disease.

Authors:  L Quintanilla-Martinez; M Kremer; G Keller; M Nathrath; A Gamboa-Dominguez; A Meneses; L Luna-Contreras; A Cabras; H Hoefler; A Mohar; F Fend
Journal:  Am J Pathol       Date:  2001-12       Impact factor: 4.307

4.  Peripheral T/natural killer-cell lymphoma involving the female genital tract: a clinicopathologic study of 5 cases.

Authors:  S Nakamura; M Kato; K Ichimura; Y Yatabe; Y Kagami; R Suzuki; H Taji; E Kondo; S Asakura; M Kojima; S Murakami; K Yamao; T Tsuzuki; G K Adachi; A Miwa; T Yoshidai
Journal:  Int J Hematol       Date:  2001-01       Impact factor: 2.490

5.  L-asparaginase induced durable remission of relapsed nasal NK/T-cell lymphoma after autologous peripheral blood stem cell transplantation.

Authors:  K Nagafuji; T Fujisaki; F Arima; K Ohshima
Journal:  Int J Hematol       Date:  2001-12       Impact factor: 2.490

6.  The diagnosis of sinonasal lymphoma: a challenge for rhinologists.

Authors:  Ting-Ting Yen; Ren-Ching Wang; Rong-San Jiang; Shyh-Chang Chen; Shang-Heng Wu; Kai-Li Liang
Journal:  Eur Arch Otorhinolaryngol       Date:  2011-11-26       Impact factor: 2.503

7.  Successful treatment of refractory advanced nasal NK/T cell lymphoma with unrelated cord blood stem cell transplantation incorporating focal irradiation.

Authors:  Yasuo Mori; Takatoshi Aoki; Katsuto Takenaka; Takuji Yamauchi; Asataro Yamamoto; Kenjiro Kamezaki; Hiromi Iwasaki; Naoki Harada; Toshihiro Miyamoto; Koji Nagafuji; Takanori Teshima; Koichi Akashi
Journal:  Int J Hematol       Date:  2009-12-02       Impact factor: 2.490

Review 8.  Diagnosis and treatment of Epstein-Barr virus-associated natural killer cell lymphoproliferative disease.

Authors:  Keisei Kawa
Journal:  Int J Hematol       Date:  2003-07       Impact factor: 2.490

Review 9.  L-asparaginase-Based induction therapy for advanced extranodal NK/T-cell lymphoma.

Authors:  Kosuke Obama; Mitsutoshi Tara; Kiyoshige Niina
Journal:  Int J Hematol       Date:  2003-10       Impact factor: 2.490

10.  Survival trends for extranodal NK/T-cell lymphoma, nasal type from different anatomical sites: a population-based study.

Authors:  Lu He; Yixin Zou; Xiaolu Tang; Jia Wang; Lingxiao Xing; Jing Zhang; Jianyong Li; Jingjing Guo; Yi Miao
Journal:  Ann Transl Med       Date:  2021-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.